(Q34458120)

2 August 2017

1 reference

title

Recombinant factor VIIa (Novoseven) and the safety of treatment (English)

1 reference

2 August 2017

H R Roberts

1

1 reference

2 August 2017

publication date

1 October 2001

1 reference

2 August 2017

published in

Seminars in Hematology

1 reference

2 August 2017

volume

38

1 reference

2 August 2017

issue

4 Suppl 12

1 reference

2 August 2017

page(s)

48-50

1 reference

Disseminated intravascular coagulation and hemorrhage in hemophilia B following elective surgery

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990148-9

7 January 2021

Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990148-9

7 January 2021

Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990148-9

7 January 2021

A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990148-9

7 January 2021

Myocardial infarction complicating activated prothrombin complex concentrate substitution in patient with hemophilia A.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990148-9

7 January 2021

Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI Group

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990148-9

7 January 2021

Factor VIIa in the treatment of haemophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990148-9

7 January 2021

10.1016/S0037-1963(01)90148-9

Identifiers

DOI

1 reference

2 August 2017

1 reference